Clinical trials
Infarction clinical trials
Below are recruiting infarction clinical trials, each written for real people, not researchers. We’re tracking 392 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04113356Recruiting
MRI study after first heart attack treated with fast angioplasty
This trial tests how well a heart MRI can be used soon after a first heart attack, especially when a blocked artery is opened quickly with angioplasty. It may help doctors better assess heart injury and guide care after an emergency heart event.
InnsbruckAges 18 years+ - NCT07130409Recruiting
Heart imaging after emergency angioplasty for first heart attack
This study uses advanced heart scans (MRI) before and after a common artery-opening procedure to see how the heart heals. It only includes people having their first heart attack who get emergency treatment with a stent.
Qingdao, ShandongAges 18–80 - NCT05604131RecruitingPhase 2
Cardiac MRI-guided iron-chelator treatment after a heart attack
This Phase 2 trial tests whether giving deferiprone (an “iron-chelator,” meaning it helps remove excess iron) guided by cardiac MRI can improve outcomes after an acute anterior heart attack. It aims to study safety and benefit for people who can undergo MRI with contrast and meet specific heart, kidney, liver, and blood criteria.
Indianapolis, IndianaAges 18–79 - NCT06669520Recruiting
Renalase and blood vessel blockages after heart attack
This study is looking at a protein in the blood (renalase) and how it relates to blockages in tiny blood vessels after a heart attack. Researchers want to see if this protein can help predict recovery, which could lead to better treatments.
Changsha, HunanAges 18 years+ - NCT07537296Recruiting
Heart Imaging Study After Heart Attack
This study uses advanced CT scans to take detailed pictures of your heart and blood vessels after a recent heart attack treated with stent placement. The goal is to better understand heart damage and predict long-term outcomes.
Nanjing, JiangsuAges 18 years+ - NCT07684924Recruiting
Early FAPI PET/MRI after a heart attack
This study uses a new type of PET/MR scan (FAPI) to look at inflammation in the heart shortly after a heart attack. It may help doctors understand recovery better and guide future treatments.
AnkaraAges 18–90 - NCT07181356Recruiting
Remote Ischemic Preconditioning for Heart Attack Recovery
This study tests whether a simple, noninvasive procedure called Remote Ischemic Preconditioning (RIPC) — where a blood pressure cuff is briefly tightened on an arm or leg — can improve long-term recovery for people who have had a heart attack. The treatment is done many times over a long period to see if it helps the heart heal and reduces future problems.
Zhengzhou, HenanAges 18 years+ - NCT06732648RecruitingPhase 2/Phase 3
Testing a new drug for severe brain swelling after a large stroke
This trial tests a new drug called HRS8179 to reduce severe brain swelling after a large stroke. If you have a major stroke on one side of the brain and can start treatment within 10 hours, this study may help prevent dangerous pressure buildup.
Beijing, Beijing MunicipalityAges 18–80 - NCT07090941Recruiting
Clot removal for severe basilar artery stroke
This trial tests a procedure to remove a blood clot from the main artery at the back of the brain (basilar artery) in people who have a large stroke. The goal is to see if this treatment can improve recovery even when the stroke damage is bigger than usual.
Haikou, HainanAges 18 years+ - NCT04528511Recruiting
Studying new atrial fibrillation after heart attack
This study looks at how often atrial fibrillation happens soon after an acute heart attack, and who is most at risk. It may help doctors identify patients who need closer heart-rhythm monitoring after a hospital heart attack.
Kaifeng, HenanAges 18 years+ - NCT06924996Enrolling by invitation
Thrombectomy for large stroke in back of the brain
This trial is testing whether a clot removal procedure, called endovascular thrombectomy, can help people who have a large stroke in the back part of the brain. To be eligible, the stroke must be from a blocked artery in the base of the skull, and the stroke must be severe and recent.
Beijing, Beijing MunicipalityAges 18–80 - NCT07208006Recruiting
Early cholesterol-lowering drug after heart attack
This trial tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early after a heart attack can help prevent further heart problems. It is for people who have had a recent heart attack and have blockages in more than one heart artery.
Shanghai, Shanghai MunicipalityAges 18–100 - NCT07202143RecruitingPhase 3
Steroid treatment for severe stroke with low lymphocyte count
This trial tests if the steroid methylprednisolone helps people who have had a major stroke and also have low infection-fighting white blood cells (lymphocytes). It is for patients who are getting a procedure to remove the clot (thrombectomy) within 24 hours of the stroke.
Fuzhou, FujianAges 18 years+ - NCT06887699Recruiting
AI ECG for heart attack care in emergency
This trial is testing whether using artificial intelligence to read ECGs in the emergency department helps doctors better manage heart attacks, especially under a new payment system. It may help speed up treatment and improve care.
Kaohsiung City, TaiwanAges 18 years+ - NCT05862103Recruiting
Long-term follow-up for people after a heart attack
This trial is a long-term check-in for people who survived a heart attack and already took part in an earlier study through a 1-year follow-up. The goal is to learn what happens over time after the heart attack and how participants are doing.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06811194Enrolling by invitation
ECG to detect past heart attacks
This trial uses an electrocardiogram (ECG) to find people who have had a past heart attack or are at high risk for coronary artery disease. It may help understand how ECG patterns relate to heart health.
Chengdu, SichuanAges 35–85 - NCT06364150RecruitingPhase 3
Stem cell treatment for recent heart attack
This trial tests whether giving specially prepared stem cells from your own blood can help your heart recover after a heart attack. You must have had a successful angioplasty or stenting within the last 4 weeks.
SeoulAges 19–80 - NCT06515730RecruitingPhase 4
Apixaban vs warfarin for left ventricle clot after heart attack
This trial tests whether a newer blood thinner, apixaban, works better than the standard warfarin for treating blood clots in the left ventricle after a heart attack. The goal is to see which medication is safer and more effective at preventing complications.
FalunAges 18 years+ - NCT07537868RecruitingPhase 2
Montelukast to reduce heart damage after heart attack
This study tests whether montelukast (a medication that reduces inflammation) can limit heart damage when given immediately after a sudden heart attack. Researchers will measure inflammation markers and heart injury to see if this drug helps patients recover better.
Al MansurahAges 30–75 - NCT07345702Recruiting
Endovascular therapy for large core posterior stroke
This trial tests endovascular therapy (a procedure to remove a clot through a tube in an artery) versus medical management for people with a severe stroke due to a blockage in the back part of the brain (basilar artery) and a large area of brain damage. The goal is to see if the procedure improves outcomes compared to medication alone.
Beijing, Beijing MunicipalityAges 18 years+ - NCT03412435Recruiting
Heart attack registry study for patients diagnosed by angiography
This study is a registry, meaning it collects health information from people who are diagnosed with a heart attack. It may help doctors better understand heart attacks and improve care for future patients.
SeoulAges 19 years+ - NCT04046237Recruiting
Treating gum disease to study heart artery inflammation after a heart attack
This study tests whether treating severe gum disease in people who recently had a heart attack can reduce inflammation in the artery plaque. It may help researchers understand if gum treatment could benefit heart health after a heart attack.
ParisAges 30–70 - NCT04088682Recruiting
Check hospital care quality for adults with heart attacks
This trial looks at how well hospitals measure and deliver care for adults who arrive soon after a certain type of heart attack. It may help improve quality of treatment for people with acute ST-elevation myocardial infarction (a specific heart attack pattern).
Beijing, Beijing MunicipalityAges 18 years+ - NCT04130269Recruiting
Study of stress, anxiety, and pain after heart attack
This study looks at how anxiety, stress, and pain may affect people after a heart attack. It may help researchers understand who could benefit from supportive strategies after myocardial infarction (heart attack).
Graz, StyriaAges 19–90
Hear when a new Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infarction?
- Yes. Clin2 currently lists 392 recruiting infarction studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infarction trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infarction trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.